ReportLinker INTRODUCTION Over the past few years, there has been an evident growth in the pipeline of cell-based products, fueled by the demand for effective therapeutics. However, such products are often temperature sensitive, requiring freezing / cryogenic conditions for transport and storage
SAN FRANCISCO--(BUSINESS WIRE)--Ossium Health, Inc., a clinical-stage bioengineering company developing cellular therapeutics to revolutionize treatment of blood, immune, and inflammatory diseases, announced today that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for OSSM-001, a mesenchymal stem cell (MSC) product, for the treatment of refractory perianal fistulas in patients with Crohns disease.
Learn How Celltex Can Improve Your Quality of Life Celltex is different from other regenerative medicine companies in virtually every way. We use our own proprietary technology to isolate, cryopreserve and culture hundreds of millions of Mesenchymal Stem Cells (MSCs) to unparalleled levels of purity and potency in our state-of-the art, FDA current Good Manufacturing Practices (cGMP)-compliant laboratory. Celltex-produced MSCs have been used in over 9,000 therapies and have improved the quality of life for countless clients, all from one small sample of adipose tissue
If youve been to a paediatric or gynaecologist of late, odds are youll have noticed pamphlets explaining cord banking opportunities. Wonder if its right for you or even if you should consider it?
Added 18,985 New Subscribers in 3Q22Revenues Up 9.1% YoY to RMB317.2 Million ($49.8 Million) Gross Profit Up 9.8% YoY to RMB269.9 Million ($42.4 Million)Operating Income Up 20.8% YoY to RMB149.7 Million ($23.5 Million) Non-GAAP Operating Income Up 18.6% YoY to RMB161.6 Million ($25.4 Million)Conference Call to be Held on March 1, 2022, at 8:00 a.m. ET HONG KONG, Feb.
Earnings Call Scheduled for 8:00 a.m. ET on March 1, 2022 HONG KONG, Feb. 23, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release its financial results for the third quarter and first nine months of fiscal 2022 on Monday, February 28, 2022, after the U.S
The high prevalence of childhood cancer in India is gradually becoming an undeniable sobering fact, and is emerging as a definite cause for alarm. Despite the fact that childhood cancers are less common than adult cancers, there is a pattern for growing tendency in cancers in children and adolescents
Biomedicines. 2014 Mar; 2(1): 5079. Received 2013 Nov 19; Revised 2014 Jan 10; Accepted 2014 Feb 17.
Every day, thousands of wisdom teeth and the healthy, viable stem cells that live within the dental pulp are extracted and discarded as medical waste. But as doctors and researchers are unlocking therapeutic uses for these valuable stem cells, more patients are opting to bank them
Table of Contents 1. Market Scope 1.1
Recent Comments